Location History:
- Zhejiang, CN (2020)
- Hangzhou, CN (2022)
Company Filing History:
Years Active: 2020-2025
Title: Yuning Hua: Innovator in Pharmaceutical Chemistry
Introduction
Yuning Hua is a prominent inventor based in Zhejiang, China, known for his significant contributions to pharmaceutical chemistry. He holds three patents that focus on innovative processes and formulations for treating various medical conditions.
Latest Patents
One of his latest patents is titled "Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof." This invention relates to solid forms of certain N-(pyrimidinyloxy)acrylamide derivatives that are useful in treating proliferation and immunological disorders, as well as diseases related to the dysregulation of kinases, including EGFR and others. The patent provides methods for making these materials, their salts, polymorphs, and pharmaceutical compositions that can treat conditions such as tumors, inflammatory diseases, autoimmune diseases, and more.
Another notable patent involves a pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamide). This invention also focuses on methods of making certain pyrrolopyrimidine derivatives that are beneficial in treating proliferation disorders and diseases related to kinase dysregulation.
Career Highlights
Yuning Hua has worked with several reputable companies, including Acea Therapeutics, Inc. and Hangzhou Acea Pharmaceutical Research Co., Ltd. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Some of his notable coworkers include Long Mao and Jia Liu, who have collaborated with him on various projects in the field of pharmaceutical chemistry.
Conclusion
Yuning Hua's innovative work in pharmaceutical chemistry, particularly in the development of new treatments for complex diseases, showcases his significant impact on the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.